Table of Content



1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Generics in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Generics in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Generics in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Generics in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Generics in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Generics in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Generics in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Generics in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Generics in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Company Profiles

30.1. Teva Pharmaceutical Industries Ltd

30.2. Viatris Inc

30.3. Sun Pharmaceutical Industries Ltd

30.4. Novartis AG

30.5. Sandoz Group AG

30.6. Hikma Pharmaceuticals Plc

30.7. Sanofi

30.8. Les Laboratoires Servier SAS

30.9. Stada Arzneimittel AG

30.10. Bayer AG

30.11. Lupin Ltd

30.12. Aspen Pharmacare Holdings Ltd

30.13. EMS SA

30.14. Eurofarma Laboratorios SA

30.15. Ache Laboratorios Farmaceuticos SA

30.16. Apotex Inc

30.17. Teva Canada Ltd

30.18. Sandoz Canada Inc

30.19. CSPC Pharmaceutical Group Ltd

30.20. Sino Biopharmaceutical Ltd

30.21. Hansoh Pharmaceutical Group Co Ltd

30.22. Dr. Reddy’s Laboratories Ltd

30.23. Cipla Ltd

30.24. Aurobindo Pharma Ltd

30.25. PT Kalbe Farma Tbk

30.26. PT Indofarma Tbk

30.27. PT Sanbe Farma

30.28. PT Soho Global Health Tbk

30.29. Friulchem SpA

30.30. DOC Generici SRL

30.31. Recordati SpA

30.32. Daiichi Sankyo Co Ltd

30.33. Towa Pharmaceutical Co Ltd

30.34. Sawai Group Holdings Co Ltd

30.35. Toho Holdings Co Ltd

30.36. Laboratorios Silanes SA de CV

30.37. Pfizer Inc

30.38. Biocad

30.39. R-Pharm

30.40. Pharmstandard

30.41. AstraZeneca Plc

30.42. Bluefish Pharmaceuticals AB

30.43. Navamedic ASA

30.44. Novartis International AG

30.45. Beacons Pharmaceuticals Pte Ltd

30.46. Abbott Laboratories SA

30.47. Adcock Ingram Holdings Ltd

30.48. Dongkook Pharmaceutical Co Ltd

30.49. JW Holdings Corp

30.50. Hanmi Pharmaceuticals Co Ltd

30.51. Dong Wha Pharma Co Ltd

30.52. Esteve Pharmaceuticals SA

30.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS

30.54. Deva Holding AS

30.55. Sandoz Inc

31 Appendix

31.1. Methodology

31.2. About MarketLine



List of Figures

List of Figures
Figure 1: Global generics market value: $ million, 2018-23
Figure 2: Global generics market volume: % of total pharma volume, 2018-23
Figure 3: Global generics market geography segmentation: % share, by value, 2023
Figure 4: Global generics market value forecast: $ million, 2023-28
Figure 5: Global generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the global generics market, 2023
Figure 7: Drivers of buyer power in the global generics market, 2023
Figure 8: Drivers of supplier power in the global generics market, 2023
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2023
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2023
Figure 11: Drivers of degree of rivalry in the global generics market, 2023
Figure 12: Asia-Pacific generics market value: $ million, 2018-23
Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2018-23
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2023
Figure 15: Asia-Pacific generics market value forecast: $ million, 2023-28
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2023-28
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2023
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2023
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2023
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2023
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2023
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2023
Figure 23: Europe generics market value: $ million, 2018-23
Figure 24: Europe generics market volume: % of total pharma volume, 2018-23
Figure 25: Europe generics market geography segmentation: % share, by value, 2023
Figure 26: Europe generics market value forecast: $ million, 2023-28
Figure 27: Europe generics market volume forecast: % of total pharma volume, 2023-28
Figure 28: Forces driving competition in the generics market in Europe, 2023
Figure 29: Drivers of buyer power in the generics market in Europe, 2023
Figure 30: Drivers of supplier power in the generics market in Europe, 2023
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2023
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2023
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2023
Figure 34: France generics market value: $ million, 2018-23
Figure 35: France generics market volume: % of total pharma volume, 2018-23
Figure 36: France generics market geography segmentation: % share, by value, 2023
Figure 37: France generics market value forecast: $ million, 2023-28
Figure 38: France generics market volume forecast: % of total pharma volume, 2023-28
Figure 39: Forces driving competition in the generics market in France, 2023
Figure 40: Drivers of buyer power in the generics market in France, 2023
Figure 41: Drivers of supplier power in the generics market in France, 2023
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2023
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2023
Figure 44: Drivers of degree of rivalry in the generics market in France, 2023
Figure 45: Germany generics market value: $ million, 2018-23
Figure 46: Germany generics market volume: % of total pharma volume, 2018-23
Figure 47: Germany generics market geography segmentation: % share, by value, 2023
Figure 48: Germany generics market value forecast: $ million, 2023-28
Figure 49: Germany generics market volume forecast: % of total pharma volume, 2023-28
Figure 50: Forces driving competition in the generics market in Germany, 2023
Figure 51: Drivers of buyer power in the generics market in Germany, 2023
Figure 52: Drivers of supplier power in the generics market in Germany, 2023
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2023
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2023
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2023
Figure 56: Italy generics market value: $ million, 2018-23
Figure 57: Italy generics market volume: % of total pharma volume, 2018-23
Figure 58: Italy generics market geography segmentation: % share, by value, 2023
Figure 59: Italy generics market value forecast: $ million, 2023-28
Figure 60: Italy generics market volume forecast: % of total pharma volume, 2023-28
Figure 61: Forces driving competition in the generics market in Italy, 2023
Figure 62: Drivers of buyer power in the generics market in Italy, 2023
Figure 63: Drivers of supplier power in the generics market in Italy, 2023
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2023
Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2023
Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2023
Figure 67: Japan generics market value: $ million, 2018-23
Figure 68: Japan generics market volume: % of total pharma volume, 2018-23
Figure 69: Japan generics market geography segmentation: % share, by value, 2023
Figure 70: Japan generics market value forecast: $ million, 2023-28
Figure 71: Japan generics market volume forecast: % of total pharma volume, 2023-28
Figure 72: Forces driving competition in the generics market in Japan, 2023
Figure 73: Drivers of buyer power in the generics market in Japan, 2023
Figure 74: Drivers of supplier power in the generics market in Japan, 2023
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan, 2023
Figure 76: Factors influencing the threat of substitutes in the generics market in Japan, 2023
Figure 77: Drivers of degree of rivalry in the generics market in Japan, 2023
Figure 78: Australia generics market value: $ million, 2018-23
Figure 79: Australia generics market volume: % of total pharma volume, 2018-23
Figure 80: Australia generics market geography segmentation: % share, by value, 2023
Figure 81: Australia generics market value forecast: $ million, 2023-28
Figure 82: Australia generics market volume forecast: % of total pharma volume, 2023-28
Figure 83: Forces driving competition in the generics market in Australia, 2023
Figure 84: Drivers of buyer power in the generics market in Australia, 2023
Figure 85: Drivers of supplier power in the generics market in Australia, 2023
Figure 86: Factors influencing the likelihood of new entrants in the generics market in Australia, 2023
Figure 87: Factors influencing the threat of substitutes in the generics market in Australia, 2023
Figure 88: Drivers of degree of rivalry in the generics market in Australia, 2023
Figure 89: Canada generics market value: $ million, 2018-23
Figure 90: Canada generics market volume: % of total pharma volume, 2018-23
Figure 91: Canada generics market geography segmentation: % share, by value, 2023
Figure 92: Canada generics market value forecast: $ million, 2023-28
Figure 93: Canada generics market volume forecast: % of total pharma volume, 2023-28
Figure 94: Forces driving competition in the generics market in Canada, 2023
Figure 95: Drivers of buyer power in the generics market in Canada, 2023
Figure 96: Drivers of supplier power in the generics market in Canada, 2023

List of Tables

List of Tables
Table 1: Global generics market value: $ million, 2018-23
Table 2: Global generics market volume: % of total pharma volume, 2018-23
Table 3: Global generics market geography segmentation: $ million, 2023
Table 4: Global generics market value forecast: $ million, 2023-28
Table 5: Global generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Global Size of Population (million), 2019-23
Table 7: Global real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 8: Global GDP (Current Prices, $ Billion), 2019-23
Table 9: Global Inflation, 2019-23
Table 10: Global Consumer Price Index (Absolute), 2019-23
Table 11: Global exchange rate, 2018-23
Table 12: Asia-Pacific generics market value: $ million, 2018-23
Table 13: Asia-Pacific generics market volume: % of total pharma volume, 2018-23
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2023
Table 15: Asia-Pacific generics market value forecast: $ million, 2023-28
Table 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2023-28
Table 17: Europe generics market value: $ million, 2018-23
Table 18: Europe generics market volume: % of total pharma volume, 2018-23
Table 19: Europe generics market geography segmentation: $ million, 2023
Table 20: Europe generics market value forecast: $ million, 2023-28
Table 21: Europe generics market volume forecast: % of total pharma volume, 2023-28
Table 22: Europe Size of Population (million), 2019-23
Table 23: Europe real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 24: Europe GDP (Current Prices, $ Billion), 2019-23
Table 25: Europe Inflation, 2019-23
Table 26: Europe Consumer Price Index (Absolute), 2019-23
Table 27: Europe exchange rate, 2018-23
Table 28: France generics market value: $ million, 2018-23
Table 29: France generics market volume: % of total pharma volume, 2018-23
Table 30: France generics market geography segmentation: $ million, 2023
Table 31: France generics market value forecast: $ million, 2023-28
Table 32: France generics market volume forecast: % of total pharma volume, 2023-28
Table 33: France Size of Population (million), 2019-23
Table 34: France real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 35: France GDP (Current Prices, $ Billion), 2019-23
Table 36: France Inflation, 2019-23
Table 37: France Consumer Price Index (Absolute), 2019-23
Table 38: France exchange rate, 2018-23
Table 39: Germany generics market value: $ million, 2018-23
Table 40: Germany generics market volume: % of total pharma volume, 2018-23
Table 41: Germany generics market geography segmentation: $ million, 2023
Table 42: Germany generics market value forecast: $ million, 2023-28
Table 43: Germany generics market volume forecast: % of total pharma volume, 2023-28
Table 44: Germany Size of Population (million), 2019-23
Table 45: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 46: Germany GDP (Current Prices, $ Billion), 2019-23
Table 47: Germany Inflation, 2019-23
Table 48: Germany Consumer Price Index (Absolute), 2019-23
Table 49: Germany exchange rate, 2018-23
Table 50: Italy generics market value: $ million, 2018-23
Table 51: Italy generics market volume: % of total pharma volume, 2018-23
Table 52: Italy generics market geography segmentation: $ million, 2023
Table 53: Italy generics market value forecast: $ million, 2023-28
Table 54: Italy generics market volume forecast: % of total pharma volume, 2023-28
Table 55: Italy Size of Population (million), 2019-23
Table 56: Italy real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 57: Italy GDP (Current Prices, $ Billion), 2019-23
Table 58: Italy Inflation, 2019-23
Table 59: Italy Consumer Price Index (Absolute), 2019-23
Table 60: Italy exchange rate, 2018-23
Table 61: Japan generics market value: $ million, 2018-23
Table 62: Japan generics market volume: % of total pharma volume, 2018-23
Table 63: Japan generics market geography segmentation: $ million, 2023
Table 64: Japan generics market value forecast: $ million, 2023-28
Table 65: Japan generics market volume forecast: % of total pharma volume, 2023-28
Table 66: Japan Size of Population (million), 2019-23
Table 67: Japan real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 68: Japan GDP (Current Prices, $ Billion), 2019-23
Table 69: Japan Inflation, 2019-23
Table 70: Japan Consumer Price Index (Absolute), 2019-23
Table 71: Japan exchange rate, 2018-23
Table 72: Australia generics market value: $ million, 2018-23
Table 73: Australia generics market volume: % of total pharma volume, 2018-23
Table 74: Australia generics market geography segmentation: $ million, 2023
Table 75: Australia generics market value forecast: $ million, 2023-28
Table 76: Australia generics market volume forecast: % of total pharma volume, 2023-28
Table 77: Australia Size of Population (million), 2019-23
Table 78: Australia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 79: Australia GDP (Current Prices, $ Billion), 2019-23
Table 80: Australia Inflation, 2019-23
Table 81: Australia Consumer Price Index (Absolute), 2019-23
Table 82: Australia exchange rate, 2018-23
Table 83: Canada generics market value: $ million, 2018-23
Table 84: Canada generics market volume: % of total pharma volume, 2018-23
Table 85: Canada generics market geography segmentation: $ million, 2023
Table 86: Canada generics market value forecast: $ million, 2023-28
Table 87: Canada generics market volume forecast: % of total pharma volume, 2023-28
Table 88: Canada Size of Population (million), 2019-23
Table 89: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 90: Canada GDP (Current Prices, $ Billion), 2019-23
Table 91: Canada Inflation, 2019-23
Table 92: Canada Consumer Price Index (Absolute), 2019-23
Table 93: Canada exchange rate, 2018-23
Table 94: China generics market value: $ million, 2018-23
Table 95: China generics market volume: % of total pharma volume, 2018-23
Table 96: China generics market geography segmentation: $ million, 2023
Table 97: China generics market value forecast: $ million, 2023-28
Table 98: China generics market volume forecast: % of total pharma volume, 2023-28
Table 99: China Size of Population (million), 2019-23
Table 100: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 101: China GDP (Current Prices, $ Billion), 2019-23
Table 102: China Inflation, 2019-23
Table 103: China Consumer Price Index (Absolute), 2019-23
Table 104: China exchange rate, 2018-23